Vancomycin: Clinical Trials

3 trials for Vancomycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 3

Follow Vancomycin: new trials by email Literature Review of Vancomycin trials Research Report on Vancomycin

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
T2Bacteria® Panel (direct-from-blood testing), Usual Care - Bloodstream Infection, Sepsis Bacterial
Not applicableCompletedVanderbilt University Medical Center5002023-12-132026-02-27
Clinical Decision Support Tool for Vancomycin Dosing in Children
Computer Decision Support Tool Intervention Group, Matched Historical Controls - Gram-Positive Bacterial Infections, Vancomycin
Not applicableCompletedUniversity of Maryland, Baltimore752022-05-092025-05-14
Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population
Vancomycin dose adjustment using the Bayesian method, Vancomycin dose adjustment using the trough level method - Vancomycin, Adult
Not applicableCompletedCR-CSSS Champlain-Charles-Le Moyne452021-03-012021-09-10

Narrower conditions

Sepsis (2)  ·  Gram-Positive Bacterial Infections (1)

Broader conditions

Infections (2)  ·  Inflammation (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)

Interventions

Standard of Care (1)

Sponsors

CR-CSSS Champlain-Charles-Le Moyne (1)  ·  University of Maryland, Baltimore (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Matthew Semler, MD, MSc (1)

Results publications

PMID 39800394

NIH funding

T32HD087969 (1)